Form D · Biotechnology
Barricade Therapeutics Corp
Fort Worth, TX · CIK 0002090859
Offering snapshot reported Jun 10, 2026 · SEC filing
- Reported sold
- $100K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 10, 2026 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-586905
SAFE
Source: Form D, filed Jun 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neil Thapar | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1120 South Freeway Suite 103
Fort Worth, TX, 76104
Fort Worth, TX, 76104